A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder

Takuya Masui, Ryota Hashimoto, Ichiro Kusumi, Katsuji Suzuki, Teruaki Tanaka, Shin Nakagawa, Tatsuyo Suzuki, Nakao Iwata, Norio Ozaki, Tadafumi Kato, Masatoshi Takeda, Hiroshi Kunugi, Tsukasa Koyama

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Lithium is one of the most commonly used drugs for the treatment of bipolar disorder. To prescribe lithium appropriately to patients, predictors of response to this drug were explored, and several genetic markers are considered to be good candidates. We previously reported a significant association between genetic variations in the breakpoint cluster region (BCR) gene and bipolar disorder. In this study, we examined a possible relationship between response to maintenance treatment of lithium and Asn796Ser single-nucleotide polymorphism in the BCR gene. Genotyping was performed in 161 bipolar patients who had been taking lithium for at least 1 year, and they were classified into responders for lithium mono-therapy and non-responders. We found that the allele frequency of Ser796 was significantly higher in non-responders than in responders. Further investigation is warranted to confirm our findings.

Original languageEnglish
Pages (from-to)204-208
Number of pages5
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume32
Issue number1
DOIs
Publication statusPublished - 01-01-2008

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Biological Psychiatry

Fingerprint Dive into the research topics of 'A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder'. Together they form a unique fingerprint.

  • Cite this

    Masui, T., Hashimoto, R., Kusumi, I., Suzuki, K., Tanaka, T., Nakagawa, S., Suzuki, T., Iwata, N., Ozaki, N., Kato, T., Takeda, M., Kunugi, H., & Koyama, T. (2008). A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(1), 204-208. https://doi.org/10.1016/j.pnpbp.2007.08.010